Tobias Pusterla

766 citations
9 papers · 637 indexed · h-index 8
Topics
Advanced Glycation End Products research (5 papers)Immune Response and Inflammation (4 papers)S100 Proteins and Annexins (3 papers)

In The Last Decade

Tobias Pusterla

9 papers receiving 631 citations

Peers

Tobias Pusterla
Comparison fields: 5 of 76
  • Clinical Biochemistry 269
  • Molecular Biology 263
  • Immunology 250
  • Cancer Research 84
  • Epidemiology 66
Replace Lorenzo Raeli with:
Lorenzo Raeli Italy
Fang Jia-Zhu China
Jennifer Kench United States
H. R. Waterham Netherlands
Céline Chéry France
Kaiser Alam Saudi Arabia
Alena Nareika United States
Louise Tzung-Harn Hsieh Germany
Shoji Tsunekawa Japan
Vjekoslav Zaninovic United States
Tobias Pusterla relative to Lorenzo Raeli Italy Lorenzo Raeli's profile →
Citations per field
00.5×3.5×
Lorenzo Raeli · 1×
Citations per year

Countries citing papers authored by Tobias Pusterla

Since Specialization
Citations

This map shows the geographic impact of Tobias Pusterla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Pusterla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Pusterla more than expected).

Fields of papers citing papers by Tobias Pusterla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Pusterla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Pusterla. The network helps show where Tobias Pusterla may publish in the future.

Co-authorship network of co-authors of Tobias Pusterla

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Pusterla. A scholar is included among the top collaborators of Tobias Pusterla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Pusterla. Tobias Pusterla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 32
2 77
3 53
4 16
5 141
6 41
7 50
8 2
9 225

About Tobias Pusterla

Tobias Pusterla is a scholar working on Clinical Biochemistry, Immunology and Cancer Research, having authored 9 papers that have together received 637 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (5 papers), Immune Response and Inflammation (4 papers) and S100 Proteins and Annexins (3 papers). The work is most often cited by research in Clinical Biochemistry (269 citations), Immunology (250 citations) and Cancer Research (84 citations). Tobias Pusterla has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include Marco E. Bianchi, Francesco De Marchis, Roberta Palumbo, Beatriz G. Gálvez, Kenneth B. Marcu, Giulio Cossu, María Rescigno, Deepak Mittal, Emilie Vénéreau and Fabiana Saccheri. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026